Cardiovascular autonomic neuropathy in diabetes: Pathophysiology, clinical assessment and implications

被引:47
|
作者
Duque, Alice [1 ]
Mediano, Mauro Felippe Felix [1 ,2 ]
De Lorenzo, Andrea [1 ]
Rodrigues Jr, Luiz Fernando [1 ,3 ]
机构
[1] Inst Nacl Cardiol, Educ & Res Dept, Rua Laranjeiras 374, BR-22240006 Rio De Janeiro, RJ, Brazil
[2] Evandro Chagas Natl Inst Infect Dis, Oswaldo Cruz Fdn, Lab Clin Res Chagas Dis, BR-21040360 Rio De Janeiro, RJ, Brazil
[3] Univ Fed Rio de Janeiro, Inst Biomed, Dept Physiol Sci, BR-22240006 Rio De Janeiro, RJ, Brazil
关键词
Cardiovascular autonomic neuropathy; Cardiac autonomic neuropathy; Diabetes mellitus; Heart rate variability; Sympathetic autonomic nervous system; Parasympathetic autonomic nervous system; HEART-RATE-VARIABILITY; RISK-FACTORS; CARDIAC DENERVATION; OXIDATIVE STRESS; NERVOUS-SYSTEM; QT INTERVAL; MORTALITY; DIAGNOSIS; DYSFUNCTION; IMPACT;
D O I
10.4239/wjd.v12.i6.855
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular autonomic neuropathy (CAN) is a debilitating condition that mainly occurs in long-standing type 2 diabetes patients but can manifest earlier, even before diabetes is diagnosed. CAN is a microvascular complication that results from lesions of the sympathetic and parasympathetic nerve fibers, which innervate the heart and blood vessels and promote alterations in cardiovascular autonomic control. The entire mechanism is still not elucidated, but several aspects of the pathophysiology of CAN have already been described, such as the production of advanced glycation end products, reactive oxygen species, nuclear factor kappa B, and pro-inflammatory cytokines. This microvascular complication is an important risk factor for silent myocardial ischemia, chronic kidney disease, myocardial dysfunction, major cardiovascular events, cardiac arrhythmias, and sudden death. It has also been suggested that, compared to other traditional cardiovascular risk factors, CAN progression may have a greater impact on cardiovascular disease development. However, CAN might be subclinical for several years, and a late diagnosis increases the mortality risk. The duration of the transition period from the subclinical to clinical stage remains unknown, but the progression of CAN is associated with a poor prognosis. Several tests can be used for CAN diagnosis, such as heart rate variability (HRV), cardiovascular autonomic reflex tests, and myocardial scintigraphy. Currently, it has already been described that CAN could be detected even during the subclinical stage through a reduction in HRV, which is a non-invasive test with a lower operating cost. Therefore, considering that diabetes mellitus is a global epidemic and that diabetic neuropathy is the most common chronic complication of diabetes, the early identification and treatment of CAN could be a key point to mitigate the morbidity and mortality associated with this long-lasting condition.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Clinical factors associated with the recovery of cardiovascular autonomic neuropathy in patients with type 2 diabetes mellitus
    Jun, Ji Eun
    Lee, Seung-Eun
    Choi, Min Sun
    Park, Sung Woon
    Hwang, You-Cheol
    Kim, Jae Hyeon
    CARDIOVASCULAR DIABETOLOGY, 2019, 18
  • [42] PREVALENCE AND CLINICAL CORRELATES OF CARDIOVASCULAR AUTONOMIC AND PERIPHERAL DIABETIC NEUROPATHY IN PATIENTS ATTENDING DIABETES CENTERS
    ZIEGLER, D
    GRIES, FA
    MUHLEN, H
    RATHMANN, W
    SPULER, M
    LESSMANN, F
    BERGER, W
    BERGIS, K
    DAWEKE, H
    DJONLAGIC, H
    FINN, JR
    GARZOLI, G
    GRIES, FA
    GRIMM, JJ
    GRUNEKLEE, D
    GUTSCHE, P
    HENRICHS, HR
    HUBNER, P
    IRSIGLER, K
    KOBBERLING, J
    KRUCK, F
    LUFT, D
    MEHNERT, H
    PETZOLDT, R
    SACHSE, G
    SAILER, D
    SCHERNTHANER, G
    WILLMS, B
    DIABETES & METABOLISM, 1993, 19 (1BIS): : 143 - 151
  • [43] CLINICAL AND METABOLIC RISK FACTORS FOR CARDIOVASCULAR AUTONOMIC NEUROPATHY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Bondar, I. A.
    Shabelnikova, O. Yu
    TERAPEVTICHESKII ARKHIV, 2010, 82 (10) : 15 - 19
  • [44] Clinical factors associated with the recovery of cardiovascular autonomic neuropathy in patients with type 2 diabetes mellitus
    Ji Eun Jun
    Seung-Eun Lee
    Min Sun Choi
    Sung Woon Park
    You-Cheol Hwang
    Jae Hyeon Kim
    Cardiovascular Diabetology, 18
  • [45] Inflammatory markers and cardiovascular autonomic neuropathy in type 1 diabetes
    Pop-Busui, R.
    Ang, L.
    Gunaratnam, S.
    Huang, Y.
    Martin, C.
    Burant, A.
    Reis, J.
    Blakely, P.
    Vasbinder, A.
    Zhao, L.
    Mizokami-Stout, K.
    Feldman, E. L.
    Hayek, S.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S366 - S367
  • [46] Inflammatory Markers and Cardiovascular Autonomic Neuropathy in Type 1 Diabetes
    Ang, Lynn
    Gunaratnam, Sejal V. G.
    Huang, Yiyuan
    Mizokami-Stout, Kara R.
    Martin, Catherine
    Reiss, Jacob
    Burant, Aaron
    Vasbinder, Alexi
    Launius, Christopher
    Zhao, Lili
    Feldman, Eva L.
    Hayek, Salim
    Pop-Busui, Rodica
    DIABETES, 2022, 71
  • [47] Diagnosis of cardiovascular autonomic neuropathy in diabetes: as simple as possible, but not simpler?
    Pafili, K.
    Papanas, N.
    ACTA DIABETOLOGICA, 2019, 56 (05) : 601 - 602
  • [48] Squatting, a posture test for studying cardiovascular autonomic neuropathy in diabetes
    Philips, J. C.
    Marchand, M.
    Scheen, A. J.
    DIABETES & METABOLISM, 2011, 37 (06) : 489 - 496
  • [49] Diagnosis of cardiovascular autonomic neuropathy in diabetes: as simple as possible, but not simpler?
    K. Pafili
    N. Papanas
    Acta Diabetologica, 2019, 56 : 601 - 602
  • [50] Cardiovascular autonomic neuropathy and bone metabolism in Type 1 diabetes
    Hansen, C. S.
    Theilade, S.
    Lajer, M.
    Hansen, T. W.
    Rossing, P.
    DIABETIC MEDICINE, 2018, 35 (11) : 1596 - 1604